History

Creation
Creator of Laennec® is a Doctor of Medicine and Agricultural Sciences form Japan - Hieda Kentaro. Back in 1945, when he taught at the Manchurian Medical Academy, one of his colleagues brought him doctoral dissertation on Vladimir Petrovich Filatov on tissue therapy. This work is devoted to use of human placenta in wound healing during surgeries was obtained by Hiere Kentaro and captivated him with its idea.
After the tragedy of Hiroshima and Nagasaki, the issue of effective recovery of such complicated for the treatment organ as liver was very important. In 1953, the Japanese scientist returned to Japan and began developing a unique placental drug for treatment of liver (restoration of its structure and functions), and later Laennec® become such a drug.
Development
An important issue was the development of the technology of the future drug basis - "placental juice." The issue of drug safety was in the first place. It was necessary to ensure that liver treatment and maintaining the overall health and beauty of the body passed without any risk.
The natural product used for Laennec® had to be reliably cleaned of blood cells and a great number of extraneous biological components in order to avoid any complications. It was a difficult task, but a rapid development of Japanese electronics and computer technology also took place during this time. They made the country of the rising sun to become the technological leaders of the world. At the time of the computer progress, the best doctors, biologists and engineers in Japan not only developed this unique high-precision equipment, but also created the original placenta processing technology that meets the level of purity of the top-degree medical tests.
Manufacturing
Laennec® manufacturing is controlled in Japan at the State level by the State program for improvement of the nation's health. Subsidies and supervision is carried out by the Japanese Medical Department.
Not every placenta is suitable for a manufacturing of LAENNEC.
• Placenta is taken only if a birth was successful, pregnancy period was full and expectant new mother never left Japan.
• Prospective donors give in advance their written consent to the use placenta and are checked for the presence of any sexually transmitted, infectious and other diseases.
• Medical surveillance of a donor is carried out prior to birth and during 6 months thereafter.
• Placenta is tested several times in fresh and frozen form within 6 months.
• It must meet high requirements for the content of viruses and germs.
• Placental extract is disinfected in special conditions in order to destroy the yet unknown microorganisms and bacteria that may be present in it and cannot be determined by tests.

In addition to disinfection, the raw material for LAENNEC manufacturing is cleaned at the molecular level from prion and structural proteins, protein components of blood, stem cells and hormones.
Technology of multi-molecular fractionation with special filters is used for these purposes.
Due to use of high-tech placenta extraction method with molecular marking (filter) LAENNEC formulation is completely free of potentially dangerous substances.

Composition:
•Vitamins;
•Minerals;
•Amino acids;
•Peptides.

Application:
•Support and reconstitution of liver and other organs and systems;
•Treatment of various pathologies;
•Recovery and rejuvenation of body.
It is administered via intravenous or intramuscular injections, or intradermal injections in certain biologically active points.